N-((S)-1-(N-(1S,3R)-3-CHLORO-4-HYDROXY-1-ISOBUTYL-3-METHYL-2-OXOBUTYLCARBAMOYL)-2-PHENYLETHYL)(S)-4-METHYL-2-((S)-2-((MORPHOLINOMETHYL)CARBONYLAMINO)-4-PHENYLBUTYRYLAMINO)VALERAMIDE
UNII VV232TQU5F
Substance Identification & Data
This profile provides standardized clinical and technical data for N-((s)-1-(n-(1s,3r)-3-chloro-4-hydroxy-1-isobutyl-3-methyl-2-oxobutylcarbamoyl)-2-phenylethyl)(s)-4-methyl-2-((s)-2-((morpholinomethyl)carbonylamino)-4-phenylbutyrylamino)valeramide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VV232TQU5F.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1890999-52-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C40H58ClN5O7 AAUNALNLJFOTDB-NZTKNTHTSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-((s)-1-(n-(1s,3r)-3-chloro-4-hydroxy-1-isobutyl-3-methyl-2-oxobutylcarbamoyl)-2-phenylethyl)(s)-4-methyl-2-((s)-2-((morpholinomethyl)carbonylamino)-4-phenylbutyrylamino)valeramide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.